Project Number AFTD-Rothstein-2012 Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Year 2012 View Full Project Details for Development of Antisense therapy and Therapeutic biomarker for C9orf72 FTD/ALS mutation patients Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Category F. Research Resources 6. Disease Models Researcher and Organization Principal Investigator Rothstein, Jeffrey Principal Investigator First Name Jeffrey Principal Investigator Last Name Rothstein Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement Accelerating Drug Discovery for Frontotemporal Degeneration 2012 RFP FY Overall Cost $125,856 Funding Organization Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Organization Country United States Program Official Nadine Tatton (AFTD)/Lauren Friedman (ADDF) Special Initiative Accelerating Drug Discovery for Frontotemporal Degeneration - AFTD Accelerating Drug Discovery for Frontotemporal Dementia - ADDF
